Surgical Treatment of Endometrial Cancer

Lanowska Malgorzata, Brink-Spalink Verena, Hasenbein Kati, Schneider Achim, Marnitz Simone, Köhler Christhardt

Department of Gynecology, Charité University Medicine Berlin, Campus Mitte.
Department of Radiooncology, Charité University Medicine Berlin.

DOI: 10.4236/jct.2010.14028                

Abstract

Each year endometrial cancer is diagnosed in approximately 11.700 women in Germany. Operation is the therapy of choice in the primary treatment of patients with endometrial cancer. The traditional abdominal approach, vaginal, laparoscopic and robotic-assisted methods are available for the surgical treatment of EC today. This article compares and evaluates these different treatment options. With rising incidence of obesity, number of patients with endometrial cancer will also increase. However, operations in obese patients are more challenging. Laparotomy as standard therapy in endometrial cancer patients stage I and II should be replaced by laparoscopic approaches. Laparoscopy is oncologically adequate to open procedures and offers many advantages to patients. Robotic surgery in the treatment of endometrial cancer is still under evaluation. Most controversial points of treatment today are indication and extention of lymphadenectomy in different stages. In advanced tumor stages, optimal debulking should be performed in order to improve effectiveness of adjuvant chemotherapeutic and/or radiation therapy.

Keywords

Endometrial Cancer, Operative Therapy, Laparoscopic Treatment, Robotic–assisted Hysterectomy, Fertil-ity-preserving Therapy

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Krebs in Deutschland 2003-2004. “H?ufigkeiten und Trends.” 6. überarbeitete Auflage. Robert-Koch-Institut (Hrsg.) und die Gesellschaft der epidemiologschen Krebsregister in Deutschland e.V. (Hrsg.). Berlin, 2008.
[2]	J. N. Bakkum-Gamez, J. Gonzales-Bosquet, N. N. Laack, A. Mariani and S. Dowdy, “Current Issues in the Management of Endometrial Cancer,” Mayo Clinic Proceedings, Vol. 83, No.2, 2008, pp. 97-112.
[3]	A. W. Kennedy, J. M. Austin, K .Y. Look and C. B. Munger, “The Society of Gynecologic Oncologists Task Force Study of Endometrial Cancer Initial Experience,” Gynecologic Oncology, Vol. 79, No.3, 2000, pp. 379-388.
[4]	Z. Vaknin, I. Ben-Ami, D. Schneider, M. Pansky and R. Halperin, “A Comparison of Perioperative Morbidity, Perioperative Mortality, and Disease-specific Survival in Elderly Women (≧70 years) Versus Younger Women (<70 years) with Endometriod Endometrial Cancer,”International Journal of Gynecological Cancer, Vol. 19, No.5, 2009, pp. 879-883.
[5]	S. Sato, H. Itamochi, M. Shimada, S. Fujii, J. Naniwa, K. Uegaki, S. Sato, M. Nonaka, T. Ogawa and J. Kigawa, “Preoperative and Intraoperative Assessment of Depth of Myometrial Invasion in Endometrial Cancer,” International Journal of Gynecological Cancer, Vol.19, No.5, 2009, pp. 884-887.
[6]	M. Signorelli, L. Guerra, A. Buda, M. Picchio, G. Mangili, T. Dell’Anna, S. Sironi and C. Messa, “Role of the Integrated FDG PET/CT in the Surgical Management of Patients with High Risk Clinical Early Stage EndoMetrial Cancer: Detection of Pelvic Nodal Metastasis,” Gynecologic Oncology, Vol. 115, No.2, 2009, pp. 231-235.
[7]	L. Chiva, F. Lapuente, L. Gonzales-Cortijo, N. Carballo, J.F. Garcia, A. Rojo and A. Gonzales-Martin, “Sparing Fertility in Young Patients With Endometrial Cancer”, Gynecologic Oncology, Vol. 111, 2008, pp. 101-104.
[8]	M. Signorelli, G. Caspani, C. Bonazzi, V. Chiappa, P. Perego and C. Mangioni, “Fertility-sparing Treatment in Young Women with Endometrial Cancer or Atypical Complex Hyperplasia: A prospective Single-institution Experience of 21 Cases,” International Journal of Obstetrics & Gynaecology, Vol. 116, No.1, 2009, pp. 114-118.
[9]	C. E. Richter, B. Qian, M. Martel, H. Yu, M. Azodi, T. J. Rutherford and P. E. Schwartz, “Ovarian Preservation and Staging in Reproductive-age Endometrial Cancer Patients,” Gynecologic Oncology, Vol. 114, No.1, 2009, pp. 99-104.
[10]	O. Zivanovic, J. Carter, N. D. Kauff and R. R. Barakat, “A Review of the Challenges Faced in the Conservative Treatment of Young Women with Endometrial Carcinoma and Risk of Ovarian Cancer,” Gynecologic Oncology, Vol. 115, No.3, 2009, pp. 504-509.
[11]	T. S. Lee, J. W. Kim, T. J. Kim, C. H. Cho, S. Y. Ryu, H. S. Ryu, B. G. Kim, K. H. Lee, Y. M. Kim, S. B. Kang and the Korean Gynecologic Oncology Group, “Ovarian Preservation during the Surgical Treatment of Early Stage Endometrial Adenocarcinoma: Unraveling a Mystery,” Gynecologic Oncology, Vol. 115, No.1, 2009, pp. 26-31.
[12]	“Leitlinien zum Zervixkarzinom, zum Endometriumkarzinom und zu den Trophoblasttumoren, Kommission Uterus der AGO e.V. (Hrsg.) ”, 1. Auflage 2008, Zuckschwerdt Verlag München-Wien-New York.
[13]	C. H. Han, K. H. Lee, H. N. Lee, C.J. Kim, T. C. Park and J. S. Park, “ Does The Type of Hysterectomy Affect the Prognosis in Clinical Stage I Endometrial Cancer?” Journal of Obstetrics and Gynaecology Research, Vol. 36, No.3, 2010, pp. 581-587.
[14]	N. Furukawa, M. Takekuma, N. Takahashi and Y. Hirashima, “Intraoperative Evaluation of Myometrial Invasion and Histological Type and Grade in Endometrial Cancer: Diagnostic Value of Frozen Section,” Archives of Gynecology and Obstetrics, Vol. 281, No.5, 2010, pp. 913-917.
[15]	G. Pristauz, A. A. Bader, P. Regitnig, J. Haas, R. Winter and K. Tamussino, “How Accurate is Frozen Section Histology of Pelvic Lymph Nodes in Patients with Endometrial Cancer? ”Gynecologic Oncology, Vol. 115, No.1, 2009, pp. 12-17.
[16]	A. Fagotti, G. Ferrandina, R. Longo, S. Mancuso and G. Scambia, “Minilaparotomy in Early Stage Endometrial Cancer: An Alternative to Standard and Laparoscopic Treatment,”Gynecologic Oncology, Vol. 86, No.2, 2002, pp. 177-183.
[17]	K. Foley and R. B. Lee, “Surgical Complications of Obese Patients with Endometrial Carcinoma,” Gynecologic Oncology, Vol. 39, No.2, 1990, pp. 171-174.
[18]	J. C. Pavelka, I. Ben-Shachar, J. M. Fowler, N. C. Ramirez, L. J. Copeland, L. A. Eaton, T. P. Manolitsas and D. E. Cohn, “Morbid Obesity and Endometrial Cancer: Surgical, Clinical and Pathologic Outcomes in Surgically Managed Patients,” Gynecologic Oncology, Vol. 95, No.3, 2004, pp 588-592.
[19]	R .J. Lelle, G. W. Morley and W. A. Peters, “The Role of Vaginal Hysterectomy in the Treatment of Endometrial Carcinoma,” International Journal of Gynecological Cancer, Vol. 4, No.5, 1994, pp. 342-347.
[20]	J. K. Chan, Y. G. Lin, B. J. Monk, K. Tewari, J. D. Bloss and M.L. Berman, “Vaginal Hysterectomy as Primary Treatment of Endometrial Cancer in Medically Compromised Women,” Obstetrics & Gynecology, Vol. 97, No.5, 2001, pp. 707-711.
[21]	G. Massi, T. Susini and G. Amunni, “Extraperitoneal Pelvic Lymphadenectomy to Complement Vaginal Operations for Cervical and Endometrial Cancer,” International Journal of Obstetrics & Gynecology, Vol. 69, No.1, 2000, pp. 27-35.
[22]	S. C. Dowdy, G. Aletti, W. A. Cliby and K. C. Podratz, A. Mariani, “Extra-peritoneal Laparoscopic Para-aortic Lymphadenectomy - a Prospective Cohort Study of 293 Patients with Endometrial Cancer,” Obstetrics & Gynecology, Vol. 111, No.3, 2008, pp. 418-424.
[23]	P. Capmas, A. S. Bats, C. Bensaid, C. Huchon, C. Scarabin, C. Nos and F. Lecuru, “Surgical treatment of early endometrial cancer: what are the benefits of laparoscopy?”Journal of Obstetrics, Gynecology and Reproductive Biology, Vol. 38, No.7, 2009, pp. 537-544.
[24]	C. K?hler, P. Klemm, A. Schau, M. Possover, N. Krause, R. Tozzi and A. Schneider, “Introduction of Transperitoneal Lymphadenectomy in a Gynecologic Oncology Center: Analysis of 650 Laparoscopic Pelvic and/or Paraaortic Transperitoneal Lymphadenectomies,” Gynecologic Oncology, Vol. 95, No. 1, 2004, pp. 52-61.
[25]	D. Querleu, E. Leblanc, G. Cartron, F. Narducci, G. Ferron and P. Martel, “Audit of Preoperative and Early Complications of Laparoscopic Lymph Node Dissection in 1000 Gynecologic Cancer Patients,” Archives of Gynecology and Obstetrics, Vol. 195, No.5, 2006, pp. 1287-1292.
[26]	A. Martinez, D. Querleu, E. Leblanc, F. Narducci and G. Ferron, “Low Incidence of Port-side Metastases after Laparoscopic Staging of Uterine Cancer,” Gynecologic Oncology, Vol. 118, No.2, 2010, pp. 145-150.
[27]	F. Ghezzi, A. Cromi, V. Bergamini, S. Ucella, P. Beretta, M. Franchi and P. Bolis, “Laparoscopic-assisted Vaginal Hysterectomy Versus Total Laparoscopic Hysterectomy for the Management of Endometrial Cancer: a randomized clinical trial,” Journal of Minimally Invasive Gynecology, Vol. 13, No.2, 2006, pp. 114-120.
[28]	K. A. O’Hanlan, G.S. Huang, A. C. Garnier, S. L. Dibble, M.L. Reuland, L. Lopez and R. L. Pinto, “Total Laparoscopic Hysterectomy Versus total Abdominal Hysterectomy: Cohort Review of Patients with Uterine Neoplasia,” Journal of the Society of Laparoendscopic Surgeons, Vol. 9, No.3, 2005, pp. 277-286.
[29]	A. Pellegrino, M. Signorelli, R. Fruscio, A. Villa, A. Buda, P. Beretta, A. Garbi and D. Vitobello, “Feasibility and Morbidity of Total Laparoscopic Radical Hysterectomy with or without Pelvic Lymphadenectomy in Obese Women with Stage I Endometrial Cancer,” Archives of Gynecology and Obstetric, Vol. 279, No.5, 2009, pp. 655-660.
[30]	C. K. Wong, Y. H. Wong, L. S. Lo, C. M. Tai and T. K. Ng, “Laparoscopy Compared with Laparotomy for the Surgical Staging of Endometrial Carcinoma,” Journal of Obstetrics and Gynaecology Research, Vol. 31, No.4, 2005, pp. 286-290
[31]	A. Zapico, P. Fuentes, A. Grassa, F. Arnanz, J. Otazua and J. Cortes-Prieto, “Laparoscopic-assisted Vaginal Hysterectomy versus Abdominal Hysterectomy in Stages I and II Endometrial Cancer. Oparating data, Follow-up and Survival,” Gynecologic Oncology, Vol. 98, No.2, 2005, pp. 222-227.
[32]	E. Volpi, A. Ferrero, M. E. Jacomuzzi, A. P. Carus, L. Fuso, F. Martra and P. Sismondi, “Laparoscopic Treatment of Endometrial Cancer: Feasibility and Results,” European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 124, No.2, 2006, pp. 232-236.
[33]	D. Y. Kim, M. K. Kim, D. S. Suh, Y. M. Kim, Y. T. Kim, J. E. Mok and J. H. Nam, “Laparoscopic-assisted Vaginal Hysterectomy Versus Abdominal Hysterectomy in Patients with Stage I and II Endometrial Cancer,” International Journal of Gynecological Cancer, Vol. 15, No.5, 2005, pp. 932-937.
[34]	L. Frigerio, A. Gallo, F. Ghezzi , G. Trezzi, M. Lussanna and M. Franchi, “Laparoscopic-assisted Vaginal Hysterectomy Versus Abdominal Hysterectomy in Endometrial Cancer,” International Journal of Obstetrics & Gynecology, Vol. 93, No.3, 2006, pp. 209-213.
[35]	L. Tollund, B. Hansen and J. J. Kjer, “Laparoscopic-assisted Vaginal vs. Abdominal Surgery in Patients with Endometrial Cancer Stage I,” Acta Obstetricia et Gynecologica Scandinavica, Vol. 85, No.9, 2006, pp. 1138-1141.
[36]	R. Seracchioli, S. Venturoli, M. Ceccarin, M. Cantarelli, M. Ceccaroni, E. Pignotti, D. De Aloysio and P. De Iaco, “Is Total Laparoscopic Surgery for Endometrial Carcinoma at Risk of Local Recurrence? A Long Term Survival,” Anticancer Research, Vol. 25, No.3c, 2005, pp. 2423-2428.
[37]	A. N. Fader, C. M. Michener, H. E. Frasure, N. Giannios, J.L. Belinson and K. M. Zanotti, “Total Laparoscopic Hysterectomy Versus Laparoscopic-assisted Vaginal Hysterectomy in Endometrial Cancer: Surgical and Survival Outcomes,” Journal of Minimally Invasive Gynecology, Vol. 16, No.3, 2009, pp. 333-339.
[38]	S. M. Eisenkop,“Total Laparoscopic Hysterectomy with Pelvic/aortic Lymph Node Dissection for Endometrial Cancer – a Consecutive Series without Case Selection and Comparison to Laparotomy,” Gynecol Oncol, Vol. 117, No.2, 2010, pp. 216-223.
[39]	R. Tozzi, S. Malur, C. K?hler and A. Schneider, “Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy,” Gynecologic Oncology, Vol. 97, 2005, pp. 4-9.
[40]	A. Obermair, T. P. Manolitsas, Y. Leung, I.G. Hammond and A. J. McCartney, “Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy for Obese Women with Endometrial Cancer,” International Journal of Gynecological Cancer, Vol. 15, No.2, 2005, pp. 319-324.
[41]	F. Zullo, S. Palomba, T. Russo, A. Falbo, M. Costantino, A. Tolino, E. Zupi, P. Tagliaferri and S. Venuta, “A Prospective Randomized Comparison Between Laparoscopic and Laparotomic Approaches in Women with Early Stage Endometrial Cancer: A Focus on the Quality of Live,” American Journal of Obstetrics and Gynecology, Vol. 193, No.4, 2005, pp. 1344-1352.
[42]	C. G. Zorlu, T. Simsek and E. S. Ari, “Laparoscopy or Laparotomy for the Management of Endometrial Cancer,” Journal of the Society of Laparoendoscopic Surgeons, Vol. 9, No.4, 2005, pp. 442-446.
[43]	R. Tozzi, S. Malur, C. Koehler and A. Schneider, “Laparoscopy Versus Laparotomy in Endometrial Cancer: First Analysis of Survival of a Randomized Prospective Study,” Journal of Minimally Invasive Gynecology, Vol. 12, No.2, 2005, pp. 130-136.
[44]	K. M. Fram, “Laparoscopically Assisted Vaginal Hysterectomy Versus Abdominal Hysterectomy in Stage I Endometrial Cancer,” International Journal of Gynecological Cancer, Vol. 12, No.1, 2002, pp. 57-61.
[45]	M. Malzoni, R. Tinelli, F. Cosentino, C. Perone, M. Rasile, D. Iuzzolino, C. Malzoni and H. Reich, “Total Laparoscopic Hysterectomy Versus Abdominal Hysterectomy with Lymphadenectomy for Early-stage Endometrial Cancer: A Prospective Randomized study,” Gynecologic Oncology, Vol. 112, No.1, 2009, pp. 126-133.
[46]	F. Nezhat F, J. Yadav, J. Rahaman, H. Gretz and C. Cohen, “Analysis of Survival after Laparoscopic Management of Endometrial Cancer,” Journal of Minimally Invasive Gynecology, Vol. 15, No.2, 2008, pp. 181-187.
[47]	S. Palomba, A. Falbo, R. Mocciaro, T. Russo and F. Zullo, “Laparoscopic Treatment for Endometrial Cancer: A Meta-analysis of Randomized Controlled Trials (RCTs),” Gynecologic Oncology, Vol. 112, No.2, 2009, pp. 415-421.
[48]	F. Lin, Q.J. Zhang, F.Y. Zheng, H. Q. Zhao, Q. Q. Zeng, M. H. Zheng and H.Y.Zhu, “Laparoscopically Assited Versus Open Surgery for Endometrial Cancer - a Metaanalysis of Randomized Controlled Trials,” International Journal of Gynecological Cancer, Vol. 18, No.6, 2008, pp. 1315-1325.
[49]	C. B. Bijen, J. M. Briet, G. H. de Bock, H .J. Arts and J.A. Bergsma-Kadijk, M.J. Mourits, “Total Laparoscopic Hysterectomy Versus Abdominal Hysterectomy in the Treatment of Patients with Early Stage Endometrial Cancer: a Randomized Multi Center Study,” British Medical Council, Cancer, Vol. 15, 2009, pp. 9-23.
[50]	J. Walker, R. Mannel, M. Piedmonte, J. Schlaerth, N. Spirtos and G. Spiegel, “Phase III Trial of Laparoscopy Versus Laparotomy for Surgical Resection and Comprehensive Surgical Staging of Uterine Cancer: a GOG Study Founded by the National Cancer Institute,” Gynecologic Oncology, Vol. 101, sup.2, 2006, pp.177.
[51]	A. G. Visco and A. P. Advincula, “Robotic Gynecologic Surgery,” Obstetrics & Gynecology, Vol. 112, No.6, 2008, pp. 1369-1384.
[52]	J. F. Magrina, “Robotic Surgery in Gynecology”. European Journal of Gynecologic Oncology, Vol. 28, No.2, 2007, pp. 77-82.
[53]	A. P. Advincula and A. Song, “The Role of Robotic Surgery in Gynecology,” Current opinion in obstetrics & gynecology, Vol. 19, No. 14, 2007, pp. 331-336.
[54]	C. Nezhat, N.S. Saberi, B. Shahmohamady and F. Nezhat, “Robotic-assisted Laparoscopy in Gynecological Surgery,” Journal of the Society of Laparoendoscopic Surgeons, Vol. 10, No. 3, 2006, pp. 317-320.
[55]	Nezhat F., “Minimally Invasive Surgery in Gynecologic Oncology: Laparoscopy Versus Robotics.” Gynecologic Oncology, Vol. 111(2 Suppl), 2008 , pp. 29-32.
[56]	D. O. Holtz, G. Miroshnichenko, M. O. Finnegan, M. Chernick and C. J. Dunton, “Endometrial Cancer Surgery Costs: Robot Versus Laparoscopy,” Journal of Minimally Invasive Gynecology, Vol.17, No.4, 2010, pp. 500-503.
[57]	L. G. Seamon, J. M. Fowler, D. L. Richardson, M. J. Carlson, S. Valmadre, G. S. Phillips and D. E. Cohn, “A Detailed Analysis of the Learning Curve: Robotic Hysterectomy and Pelvic-aortic Lymphadenectomy for Endometrial cancer,” Gynecologic Oncology, Vol. 8, May 2009 Epub ahead of print.
[58]	R. Pareja and P. T. Ramirez, “Robotic Radical Hysterectomy in the Management of Gynecologic Malignancies,” Journal of Minimally Invasive Gynecology, Vol. 15, No. 6, 2008, pp. 673-676.
[59]	L. Mettler, T. Schollmeyer, J. Boggess, J. F. Magrina and A. Oleszczuk, “Robotic Assistance in Gynecological Oncology,” Current Opinion in Oncology, Vol. 20, No.5, 2008, pp. 581-589.
[60]	M. Peiretti, V. Zanagnolo, L. Bocciolone, F. Landoni, N. Colombo, L. Minig, F. Sanguineti and A. Maggioni,”Robotic Surgery: Changing the Surgical Approach for Endometrial Cancer in a Referral Cancer center, “Journal of Minimally Invasive Gynecology, Vol. 16, No.4, 2009, pp.427-431.
[61]	L. G. Seamon, D. E. Cohn, M. S. Henretta, S. H. Kim, M. J. Carlson, G. S. Phillips and J. M. Fowler, “Minimally Invasive Comprehensive Surgical Staging for Endometrial Cancer: Robotics or Laparoscopy?” Gynecologic Oncology, Vol. 113, No. 1, 2009, pp. 36-41.
[62]	M. C. Bell, J. Torgerson, U. Seshadri-Kreaden, A.W. Suttle and S. Hunt, “Comparison of Outcomes and Cost for Endometrial Cancer Staging via Traditional Laparotomy, standard laparoscopy and robotic techniques,” Gynecologic Oncology, Vol. 111, No.3, 2008, pp. 407-411.
[63]	J. Cardenas-Goicoechea, S. Adams, S. B. Bhat and T. C. Randall, “Surgical Outcomes of Robotic-assisted Surgical Staging for Endometrial Cancer are Equivalent to Traditional Laparoscopic Staging at Minimally Invasive Surgical Center,” Gynecologic Oncology, Vol. 117, No.2, 2010, pp. 224-228.
[64]	S. A. DeNardis, R. W. Holloway, G. E. Bigsby, D. P. Pikaart, S. Ahmad and N.J. Finkler, “Robotically Assisted Laparoscopic Hysterectomy versus Total Abdominal Hysterectomy and Lymphadenectomy for Endometrial Cancer,” Gynecologic Oncology, Vol. 111, No.3, 2008, pp. 412-417.
[65]	D. S.Veljovich, P. J. Paley, C. W. Drescher, E. N. Everett, C. Shah and W. A. Peters, “Robotic Surgery in Gynecologic Oncology: Program Initiation and Outcomes after the First Year with Comparison with Laparotomy for Endometrial Cancer Staging,” American Journal of Obstetrics and Gynecology, Vol. 198, No. 6, 2008, pp. 1-9.
[66]	J. F. Boggess, P. A. Gehrig, L. Cantrell, A. Shafer, M. Ridgway, E.N. Skinner and W.C. Fowler, “A Comparative Study of 3 Surgical Methods for Hysterectomy with Staging for Endometrial Cancer: Robotic Assistance, Laparoscopy, Laparotomy,” American Journal of Obstetrics and Gynecology, Vol. 199, No. 4, 2008, pp. 1-9.
[67]	P. A.Gehrig, L. A. Cantrell, A. Shafer, L. N. Abaid, A. Mendivil and J.F. Boggess, “What Is the Optimal Minimally Invasive Surgical Procedure for Endometrial Cancer Staging in the Obese and Morbidly Obese Woman?” Gynecologic Oncology, Vol. 111, No.1, 2008, pp. 41-45.
[68]	G. L. Seamon, D. E. Cohn , D. L. Richardson, S. Valmadre, M. J. Carlson, G. S. Phillips and J. M. Fowler, “Robotic Hysterectomy and Pelvic-aortic Lymphadenectomy for Endometrial Cancer,” Obstetrics & Gynecology, Vol. 112, No.6, 2008, pp. 1207-1213.
[69]	J. B. Field, M. F. Benoit, T. A. Dinh and C. Diaz-Arrastia, “Computer-enhanced Robotic Surgery in Gynecologic Oncology,” Surgical Endoscopy, Vol. 21, No.2, 2007, pp. 244-246.
[70]	J. M. Cragun, L. J. Havrilesky, B. Calingaert, I. Synan, A. A. Secord, J. T. Soper, D. L. Clarke-Pearson and A. Berchuck, “Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-stage Endometrial Cancer,” Journal of Clinical Oncology, Vol. 23, No.16, 2005, pp. 3668-3675.
[71]	J. K. Chan, H. W. Wu, M. K. Cheung, J. Y. Shin, K. Osann and D.S. Kapp, “The Outcomes of 20.063 Women with Unstaged Endometroid Uterine Cancer,” Gynecologic Oncology, Vol. 106, No.2, 2007, pp. 282-288.
[72]	D. C. Smith DC, O. K. Macdonald, C. M. Lee and D. K. Gaffney, “Survival Impact of Lymph Node Dissection in Endometrial Adenocarcinoma: A Surveillance, Epidemiology and End Result Analysis,” International Journal of Gynecological Cancer, Vol. 18, No.2, 2008, pp. 255-261.
[73]	A. Mariani, S. C. Dowdy, W. A. Cliby, B. S. Gostout, M.B. Jones, T. O. Wilson and K. C. Podratz, “Prospective Assessment of Lymphatic Dissemination in Endometrial Cancer: A Paradigm Shift in Surgical Staging,” Gynecologic Oncology, Vol. 109, No.1, 2008, pp. 11-18.
[74]	W. T. Creasman, F. Odicino, P. Maisonneuve, M. A. Quinn, U. Beller, J. L. Benedet, A. P. M. Heintz, H. Y. S. Ngan and S. Pecorelli, “Carcinoma of the Corpus Uteri in 26th Annual Report on the Results of Treatment in Gynaecologic Cancer,” International Journal of Gynecology Obstetrics, Vol.95, Suppl.1, 2006, pp. S105-S143.
[75]	D. S. Chi, R. R. Barakat, M. J. Palayekar, D. A. Levine, Y. Sonoda, K. Alektiar, C. L. Brown and N. R. Abu-Rustum, “The Incidence of Pelvic Lymph Node Metastasis by FIGO Staging for Patients with Adequately Surgically Staged Endometrial Adenocarcinoma of Endometroid Histology,” International Journal of Gynecological Cancer, Vol. 18, No.2, 2008, pp. 269-273.
[76]	P. Benedetti Panici, S. Basile, F. Maneschi, A. Lissoni, M. Signorelli, G. Scambia, R. Angioli, S. Tateo, G. Mangili, D. Katsaro, G. Garozzo, E. Campagnutta, N. Donadello, S. Greggi, M. Melpignano, F. Raspagliesi, N. Ragni, G. Cormio, R. Grassi, M. Franchi, D. Giannarelli, R. Fossati, V. Torri, M. Amoroso, C. Croce and C. Mangioni, “Systematic Pelvic Lymphadenectomy vs. No Lymphadenectomy in Early-stage Endometrial Carcinoma: Randomized Clinical Trail,” Journal of the National Cancer Institute, Vol. 100,
[77]	W. T. Creasman, C. P. Morrow, B. N. Bundy, H. D. Homesley, J.E. Graham and P.B. Heller, “Surgical Pathologic Spread Patterns of Endometrial Cancer. A Gynecologic Oncology Group Study,” Cancer, Vol. 60, No.8 (Suppl.), 1987, pp. 2035-2041.
[78]	ASTEC study group, H. Kitchener, A. M. Swart, Q. Qian, C. Amos and M. K. Parmar, “Efficacy of Systematic Pelvic Lymphadenectomy in Endometrial Cancer (MRC ASTEC trail): A Randomised Study,” Lancet, Vol. 373, No.9658, 2009, pp. 125-136.
[79]	R. C. Boronow, “Endometrial Cancer and Lymph Node Surgery: The Spins Continue – a Case for Reason,” Gynecologic Oncology, Vol. 111, No. 1, 2008, pp. 3-6.
[80]	J. Aalders, V. Abeler, P. Kolstad and M. Onsrud, “Postoperative External Irradiation and Prognostic Parameter in Stage I Endometrial Carcinoma: Clinical and Histopathologic Study of 540 Patients,” Obstetrics & Gynecology, Vol. 56, No.4, 1980, pp. 419-427.
[81]	C. L. Creutzberg C L, W. L. van Putten, P. C. Koper, M. L. Lybeert, J. J. Jobsen, C. C. Wárlám-Rodenhuis, K. A. De Winter, L. C. Lutgens, A. C. van den Bergh, E. van de Steen-Banasik, H. Beerman and M. van Lent, “Surgery and Postoperative Radiotherapy versus Surgery Alone for Patients with Stage-1 Endometrial Carcinoma: Multicentre Randomised Trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma,” Lancet, Vol. 355, No. 9213, 2000, pp. 1404-1411.
[82]	H. M. Keys, J. A. Roberts, V. L. Brunetto, R. J. Zaino, N.M. Spirtos, J. D. Bloss, A. Pearlman, M. A. Maiman, J. G. Bell and Gynecologic Oncology Group, “A Phase III Trial of Surgery with or without Adjunctive External Pelvic Radiation Therapy in Intermediate Risk Endometrial Adenocarcinoma: A Gynecologic Oncology Group study,” Gynecologic Oncology, Vol. 92, No.3, 2004, pp. 744-751.
[83]	ASTEC/EN.5 Study Group, P. Blake, A. M. Swart, J. Orton, H. Kitchener, T. Whelan, H. Lukka, E. Eisenhauer, M. Bacon, D. Tu, M.K. Parmar, C. Amos, C. Murray and W. Qian, “Adjuvant External Beam Radiotherapy in the Treatment of Endometrial Cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled Trial Results, Systematic Review, and Meta-analysis,” Lancet, Vol. 373, No.9658, 2009, pp. 137-146.
[84]	Y. Delpech and E. Barranger, “Management of Lymph Nodes in Endometrioid Uterine Cancer,” Current Opinion in Oncology, Vol. 22, No. 5, 2010, pp. 487-491.
[85]	E. Sartori, A. Gadducci, F. Landoni, A. Lissoni, T. Maggino, P. Zola and V. Zanagnolo, “Clinical Behavior of 203 Stage II Endometrial Cancer Cases: the Impact of Primary Surgical Approach and Adjuvant Radiation Therapy,” International Journal of Gynecological Cancer, Vol.11, No.6, 2001, pp. 430-437.
[86]	D. E.Cohn, E. M. Woeste, S. Cacchio, V. L. Zanagnolo, L. J. Havrilesky, A. Mariani, K.C. Podratz, W.K. Huh, J.M. Whitworth, D.S. McMeekin, M. A. Powell, E. Boyd, G. S. Phillips and J. M. Fowler, “Clinical and Pathologic Correlates in Surgical Stage II Endometrial Carcinoma,” Obstetrics & Gynecology, Vol. 109, No.5, 2007, pp. 1062-1067.
[87]	A. Ayhan, C. Taskiran, C. Celik and K. Yuce, “The Long-term Survival of Women with Surgical Stage II Endometrioid type Endometrial Cancer,” Obstetrics & Gynecology, Vol. 93, No.1, 2004, pp. 9-13.
[88]	A. Oleszczuk, C. K?hler, J. Paulick, A. Schneider and M. Lanowska, “Vaginal Robotic-assisted Radical Hysterectomy (VRARH) after Laparoscopic Staging: Feasibility and Operative Results,” International Journal of Medical Robotics and Computer Assisted Surgery, Vol. 5, No.1, 2009, pp. 38-44.
[89]	R. E. Bristow, M. J. Zerbe, N. B. Rosenshein, F. C. Grumbine and F.J. Montz, “Stage IVB Endometrial Cancer: the Role of Cytoreductive Surgery and Determinants of Survival,” Gynecologic Oncology, Vol. 78, No.2, 2000, pp. 85-91.
[90]	A. Ayhan, C. Taskiran, C. Celik, K. Yuce and T. Kucukali, “The Influence of Cytoreductive Surgery on Survival and Morbidity in Stage IVB Endometrial Cancer,” International Journal of Gynecological Cancer, Vol. 12, No.5, 2002, pp 448-453.
[91]	K. Nakayama, Y. Nagai, M. Ishikawa, Y. Aoki and K. Miyazaki, “Concomitant Postoperative Radiation and Chemotherapy Following Surgery was Associated with Improved Overall Survival in Patients with FIGO Stages III and IV Endometrial Cancer,”International Journal of Clinical Oncology, Vol. 24, April 2010, Epub ahead of print.
[92]	M. A.Geller, J. Ivy, K. E. Dusenberg, R. Ghebre, V. R. Isaksson and P.A. Argenta, “A Single Institution Experience Using Sequential Multi-modality Adjuvant Chemotherapy and Radiation in the Sandwich Method for High Risk Endometrial Carcinoma,” Gynecologic Oncology, Vol. 118, No.1, 2010, pp. 19-23.
[93]	A. Gadducci and C. Greco, “The Evolving Role of Adjuvant Therapy in Endometrial Cancer”, Critical Reviews in Oncology/Hematology, Vol. 23, 2010, Epub ahead of print.